Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Reset all filters
01 1Granules India Limited
02 1LGM Pharma
03 3Dr. Reddy's Laboratories
04 1Tagoor Laboratories
05 1Alembic Pharmaceuticals Limited
06 1Aurobindo Pharma Limited
07 1Baran Chemical and Pharmaceutical
08 1Biocon
09 1Guangzhou Tosun Pharmaceutical
10 1Hetero Drugs
11 1Hunan Huateng Pharmaceutical Co ltd
12 2MSN Laboratories
13 1Natco Pharma
14 1Sai Phytoceuticals
15 1Shandong Haohong Biotechnology Co.,ltd
16 1Shanghai Hope Chem
17 1Shenzhen Haorui
18 2Sichuan Elixir Pharmaceuticals
19 1Sichuan Xieli Pharmaceutical
20 1Sterling Spa
21 1Sun Pharmaceutical Industries Limited
22 1Tecoland Corporation
23 1Vannsh Life Sciences
24 1Wuhan Wuyao Pharmaceutical
25 1Zhejiang Tianyu Pharmaceutical Co., Ltd
Reset all filters
01 10China
02 15India
03 1Iran
04 1Italy
05 2U.S.A
Reset all filters
01 10Active
02 19Blank
01 29Blank
Reset all filters
01 29Blank
Reset all filters
01 1WC-0349
02 1WC-0349A3
03 27Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38207
Submission : 2023-03-31
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39141
Submission : 2023-12-01
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39274
Submission : 2023-12-29
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39757
Submission : 2024-03-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39785
Submission : 2024-03-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-17
Pay. Date : 2019-10-11
DMF Number : 34201
Submission : 2019-11-06
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-23
Pay. Date : 2022-02-28
DMF Number : 36509
Submission : 2022-02-28
Status : Active
Type : II
53
PharmaCompass offers a list of Cabozantinib S-Malate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cabozantinib S-Malate manufacturer or Cabozantinib S-Malate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cabozantinib S-Malate manufacturer or Cabozantinib S-Malate supplier.
PharmaCompass also assists you with knowing the Cabozantinib S-Malate API Price utilized in the formulation of products. Cabozantinib S-Malate API Price is not always fixed or binding as the Cabozantinib S-Malate Price is obtained through a variety of data sources. The Cabozantinib S-Malate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A cabozantinib (S)-malate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of cabozantinib (S)-malate, including repackagers and relabelers. The FDA regulates cabozantinib (S)-malate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. cabozantinib (S)-malate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of cabozantinib (S)-malate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A cabozantinib (S)-malate supplier is an individual or a company that provides cabozantinib (S)-malate active pharmaceutical ingredient (API) or cabozantinib (S)-malate finished formulations upon request. The cabozantinib (S)-malate suppliers may include cabozantinib (S)-malate API manufacturers, exporters, distributors and traders.
click here to find a list of cabozantinib (S)-malate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 25 companies offering cabozantinib (S)-malate
Get in contact with the supplier of your choice: